Clinical Trial Update: The Effects of Glucagon on Hepatic Metabolism [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes ongoing Phase 1 and Phase 2 studies of glucagon's effects on hepatic metabolism in obesity, Type 2 diabetes mellitus, and non-a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLUCAGON (GLUCAGON)

Snippet

Sponsor: Adrian Vella | Conditions: Obesity, Type2diabetes | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING